First-in-Human (Phase I) Clinical Pharmacology Support Vendors
Compare partners for first-in-human and Phase I studies: starting dose, dose escalation, early PK/PD decisions, design and execution.
Related workflows
CRO / Research Services Provider · +2 more types
Products: ClinQuick
“Over 40 years of experience: Conducting First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and clinical pharmacology research…”Source: celerion.com
Also offers: Clinical Trial Bioanalytical & Biomarker Testing, Bioavailability & Bioequivalence Studies, +1 more
CRO / Research Services Provider · +5 more types
“Over 25 years of experience in the execution of comprehensive Phase I-IIa studies”Source: frontagelab.com
Also offers: Bioanalysis & Biomarker Assay Services, Integrated CDMO/CMO Services, +2 more
CRO / Research Services Provider · +3 more types
Products: Acceleration Platform
“Altasciences is a recognized leader in conducting first-in-human studies in both healthy normal volunteers and patient populations, with both small and large molecules.”Source: altasciences.com
Also offers: Toxicology Studies, Bioanalysis & Biomarker Assay Services, +1 more
Software / Technology Platform · +4 more types
Products: GastroPlus, MonolixSuite +9 more
“We can perform PBPK modeling of preclinical data to define dosing strategies for First in Human (FIH) studies”Source: simulations-plus.com
Also offers: Model-Informed Drug Development (MIDD), PBPK Modeling, +3 more
CRO / Research Services Provider · +1 more type
“We conduct Phase I trials to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy volunteers or targeted patient populations. Our team designs customized…”Source: althian.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Marketing Authorization & Lifecycle Submission Support, +3 more
CRO / Research Services Provider · +7 more types
Products: IQVIA Vigilance Platform, SmartSolve +4 more
“With more than 43 years of deep experience in Phase I/II trials, IQVIA empowers you with faster, better-informed decisions from First-in-Human to Phase IIa — through our…”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
Consulting / Advisory Firm · +1 more type
“We see the big picture – from translational medicine, protocol development, trial design, PIND/IND strategy to first dose and beyond.”Source: tunnellconsulting.com
Also offers: GxP Compliance Consulting, Technology Transfer, Process Characterization & PPQ, +2 more
Consulting / Advisory Firm · +1 more type
Products: Twine, Narralytix +1 more
“Informed first-in-human (FIH) study design through pre-clinical data modeling”Source: bluematterconsulting.com
Also offers: Product Launch Strategy & Readiness, Market Access Strategy & Launch Planning, +2 more
Service Provider · +2 more types
Products: D.AI.M.I.
“From first-in-human studies through pivotal trials to post-approval and observational research – if your program needs clinical expertise, in Europe, and particularly in Italy and…”Source: plglifesciences.com
Also offers: Regulatory Development Strategy & Agency Interactions, End-to-End Pharmacovigilance Outsourcing, +6 more
Compare listed vendors
What this covers: Clinical pharmacology design and execution support for first-in-human and Phase I studies, including starting-dose, escalation, and early PK/PD decisions.
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Altasciences | CRO / Research Services Provider | Clinical Pharmacology Strategy | “Altasciences is a recognized leader in conducting first-in-human studies in both healthy normal volunteers and patient populations, with both small and large…”altasciences.com · reviewed Oct 21, 2026 |
| Althian Clinical Research | CRO / Research Services Provider | — | “FIH trials mark the first administration of a compound in humans — and they require meticulous planning, risk mitigation, and real-time safety monitoring. Our…”althian.com · reviewed Oct 25, 2026 |
| Blue Matter Consulting | Consulting / Advisory Firm | — | “Informed first-in-human (FIH) study design through pre-clinical data modeling”bluematterconsulting.com · reviewed Oct 22, 2026 |
| Celerion | CRO / Research Services Provider | Clinical Pharmacology Strategy | “Over 40 years of experience: Conducting First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and clinical…”celerion.com · reviewed Oct 20, 2026 |
| Frontage Laboratories | CRO / Research Services Provider | — | “Over 25 years of experience in the execution of comprehensive Phase I-IIa studies”frontagelab.com · reviewed Oct 21, 2026 |
| IQVIA | CRO / Research Services Provider | — | “With more than 43 years of deep experience in Phase I/II trials, IQVIA empowers you with faster, better-informed decisions from First-in-Human to Phase IIa —…”iqvia.com · reviewed Oct 25, 2026 |
| ProductLife Group | Service Provider | Clinical Pharmacology Strategy | “From first-in-human studies through pivotal trials to post-approval and observational research – if your program needs clinical expertise, in Europe, and…”plglifesciences.com · reviewed Oct 26, 2026 |
| Simulations Plus | Software / Technology Platform | Clinical Pharmacology Strategy | “We can perform PBPK modeling of preclinical data to define dosing strategies for First in Human (FIH) studies”simulations-plus.com · reviewed Oct 26, 2026 |
| Tunnell Consulting | Consulting / Advisory Firm | Clinical Pharmacology Strategy | “We see the big picture – from translational medicine, protocol development, trial design, PIND/IND strategy to first dose and beyond.”tunnellconsulting.com · reviewed Oct 26, 2026 |